Entrada Therapeutics, Inc. financial data

Symbol
TRDA on Nasdaq
Location
One Design Center Place, Suite 17 500, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.13K % +299%
Debt-to-equity 22.4 % -69.1%
Return On Equity -17.8 % -151%
Return On Assets -14.6 % -171%
Operating Margin -121 % -410%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38M shares +2.25%
Common Stock, Shares, Outstanding 38M shares +2.32%
Entity Public Float 393M USD -8.98%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 41.3M shares +20.9%
Weighted Average Number of Shares Outstanding, Diluted 41.3M shares +16.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 79.5M USD -66.8%
Research and Development Expense 135M USD +21.1%
General and Administrative Expense 41M USD +17.8%
Operating Income (Loss) -96.2M USD -203%
Income Tax Expense (Benefit) -3.55M USD -160%
Net Income (Loss) Attributable to Parent -73.4M USD -170%
Earnings Per Share, Basic -2 USD/shares -165%
Earnings Per Share, Diluted -2 USD/shares -167%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.5M USD -60.9%
Cash, Cash Equivalents, and Short-term Investments 354M USD -24.6%
Assets, Current 369M USD -24.6%
Property, Plant and Equipment, Net 9.81M USD -13.5%
Operating Lease, Right-of-Use Asset 65.7M USD -14%
Other Assets, Noncurrent 199K USD -73.4%
Assets 449M USD -22.9%
Accounts Payable, Current 1.86M USD +13.6%
Employee-related Liabilities, Current 4.22M USD +17.7%
Accrued Liabilities, Current 11.8M USD +7.24%
Liabilities, Current 19.8M USD -76.9%
Operating Lease, Liability, Noncurrent 49.3M USD -11.8%
Liabilities 69.3M USD -54.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 400K USD
Retained Earnings (Accumulated Deficit) -190M USD -63%
Stockholders' Equity Attributable to Parent 380M USD -11.7%
Liabilities and Equity 449M USD -22.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.5M USD -50.9%
Net Cash Provided by (Used in) Financing Activities 350K USD +69.9%
Net Cash Provided by (Used in) Investing Activities 4.78M USD -81.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 38M shares +2.27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -33.4M USD -4102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.4M USD -59.6%
Deferred Tax Assets, Valuation Allowance 62.9M USD -19.2%
Deferred Tax Assets, Gross 84.7M USD -17.4%
Operating Lease, Liability 59.2M USD -13.2%
Depreciation 3.99M USD +16%
Payments to Acquire Property, Plant, and Equipment 1.14M USD +36.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72.6M USD -169%
Lessee, Operating Lease, Liability, to be Paid 80.4M USD -15%
Property, Plant and Equipment, Gross 21.1M USD +11.7%
Operating Lease, Liability, Current 5.46M USD -36.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.83M USD -32.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 12M USD -7.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.2M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.08M USD +2.91%
Deferred Tax Assets, Operating Loss Carryforwards 1.26M USD -65.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.35M USD +2.93%
Operating Lease, Payments 2.28M USD +24.1%
Additional Paid in Capital 569M USD +4.06%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 19.7M USD +26.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%